Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Growth hormone secretion” refers to the physiological process by which growth hormone (GH) is released from the anterior pituitary gland, regulated by stimulatory (growth hormone-releasing hormone, ghrelin) and inhibitory (somatostatin) signals from the hypothalamus, as well as feedback from peripheral hormones like insulin-like growth factor 1 (IGF-1)[1][2][3][4][5][6]. It is not a discrete molecule, gene, protein, or receptor, but rather a complex process mediated primarily through the growth hormone-releasing hormone receptor (a G protein-coupled receptor, GHRHR), growth hormone receptor (type I cytokine receptor, GHR), and somatostatin receptors (GPCRs)[1][4][6]. Disruption in the secretion process can result in conditions like growth hormone deficiency or excess (acromegaly, gigantism)[2][3][6]. Therapeutic targeting in this context means modulating relevant hormones or their receptors, not targeting "growth hormone secretion" as a singular molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth hormone secretion.